Clinical Trial Update: PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis [EARLY_Phase 1]

View source ↗

Summary

An early Phase I pilot study is evaluating pafolacianine for intraoperative imaging in gastrointestinal cancer with peritoneal carcinomatosis; the trial is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• Pafolacianine (pafolacianine)

Snippet

Sponsor: University of California, Irvine | Conditions: Gastrointestinal Cancer, Peritoneal Carcinomatosis | EARLY_Phase 1 | Status: RECRUITING